Expression of CDX2 and Hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome

Pathology and Oncology Research

Volumn 17, Issue 3, 2011, Pages 561-568

  Li, Qing Long ^a   Yang, Zhu Lin ^a   Liu, Jie Qiong ^a   Miao, Xiong Ying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CDX2; Chronic cholecystitis; Clinicopathology; Gallbladder cancer; Hepatocyte antigen (Hep); Hepatocyte paraffin 1; Immunohistochemistry

Indexed keywords

HEPATOCYTE ANTIGEN; TRANSCRIPTION FACTOR CDX2; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CHRONIC CHOLECYSTITIS; COLUMNAR EPITHELIUM; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER TUMOR; GALLSTONE; GOBLET CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCUS SECRETION; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CHOLECYSTITIS; CHRONIC DISEASE; FEMALE; GALLBLADDER NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052753558     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9346-7     Document Type: Article

References (33)

1. RS Jones 1990 Carcinoma of the gallbladder Surg Clin North Am 70 1419 1428 2247823 1:STN:280:DyaK3M%2Fmt1yhug%3D%3D
2. MT Carriaga DE Henson 1995 Liver, gallbladder, extraHepatic bile ducts, and pancreas Cancer 75 171 190 8000995 10.1002/1097-0142(19950101)75:1+<171:: AID-CNCR2820751306>3.0.CO;2-2 1:STN:280:DyaK2M%2FpsVWhsg%3D%3D
3. E Suh L Chen J Taylor PG Traber 1994 A homeodomain protein related to caudal regulates intestine-specific gene transcription Mol Cell Biol 14 7340 7351 7935448 1:CAS:528:DyaK2MXhsVWlsbY%3D (Pubitemid 24326399)
4. DG Silberg GP Swain ER Suh PG Traber 2000 Cdx1 and cdx2 expression during intestinal development Gastroenterology 119 961 971 11040183 10.1053/gast.2000.18142 1:CAS:528:DC%2BD3cXnvV2gsr0%3D
5. RW Phillips HF Frierson Jr CA Moskaluk 2003 Cdx2 as a marker of epithelial intestinal differentiation in the esophagus Am J Surg Pathol 27 1442 1447 14576477 10.1097/00000478-200311000-00006 (Pubitemid 37315196)
6. A Eda H Osawa K Satoh, et al. 2003 Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa J Gastroenterol 38 14 22 12560917 10.1007/s005350300001 1:CAS:528:DC%2BD3sXovFajtw%3D%3D (Pubitemid 36267690)
7. YQ Bai H Yamamoto Y Akiyama, et al. 2002 Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach Cancer Lett 176 47 55 11790453 10.1016/S0304-3835(01)00753-4 1:CAS:528:DC%2BD38XktFarsw%3D%3D (Pubitemid 34085069)
8. H Mutoh Y Hakamata K Sato, et al. 2002 Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice Biochem Biophys Res Commun 294 470 479 12051735 10.1016/S0006-291X(02)00480-1 1:CAS:528: DC%2BD38XktlGrsLg%3D (Pubitemid 34694118)
9. HS Kim JS Lee JN Freund, et al. 2006 CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions J Gastroenterol Hepatol 21 438 442 16509871 10.1111/j.1440-1746.2005.03933.x 1:CAS:528:DC%2BD28XjvFyrurs%3D
10. D Vallbohmer SR DeMeester JH Peters, et al. 2006 Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus Dis Esophagus 19 260 266 16866857 10.1111/j.1442-2050.2006.00586.x 1:STN:280: DC%2BD28vktlOisg%3D%3D (Pubitemid 44027088)
11. D Nonaka S Kusamura D Baratti P Casali R Younan M Deraco 2006 CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases Histopathology 49 381 387 16978201 10.1111/j.1365-2559.2006.02512.x 1:STN:280:DC%2BD28rlsVSksQ%3D%3D (Pubitemid 44401545)
12. A Ishikawa M Sasaki S Ohira, et al. 2004 Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in Hepatolithiasis Lab Investigation Journal Technical Methods Pathology 84 629 638 10.1038/labinvest.3700087 1:CAS:528:DC%2BD2cXmtF2isbc%3D (Pubitemid 38858472)
13. Z Fan J Li B Dong X Huang 2005 Expression of Cdx2 and Hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis Clin Cancer Res 11 6162 6170 16144916 10.1158/1078-0432.CCR-05-0278 1:CAS:528:DC%2BD2MXpslans74%3D (Pubitemid 41262943)
14. A Jinawath Y Akiyama Y Yuasa C Pairojkul 2006 Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma J Cancer Res Clin Oncol 132 805 810 16794828 10.1007/s00432-006-0129-1 1:CAS:528:DC%2BD28XhtVeqsb7N (Pubitemid 44521456)
15. H Sakamoto H Mutoh K Ido K Satoh H Hayakawa K Sugano 2007 A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis Hum Pathol 38 66 71 16996572 10.1016/j.humpath.2006.06.010 1:CAS:528:DC%2BD28Xhtleis77L (Pubitemid 44880201)
16. YT Chang C Hsu YM Jeng MC Chang SC Wei JM Wong 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma J Gastroenterol Hepatol 22 389 394 17295772 10.1111/j.1440-1746.2006.04487.x (Pubitemid 46238770)
17. XS Wu Y Akiyama T Igari, et al. 2005 Expression of homeodomain protein CDX2 in gallbladder carcinomas J Cancer Res Clin Oncol 131 271 278 15645288 10.1007/s00432-004-0658-4 1:CAS:528:DC%2BD2MXivVOiur0%3D (Pubitemid 40558541)
18. PG Chu S Ishizawa E Wu LM Weiss 2002 Hepatocyte antigen as a marker of Hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein Am J Surg Pathol 26 978 988 12170084 10.1097/00000478-200208000-00002 (Pubitemid 34810558)
19. S Kakar AM Gown ZD Goodman LD Ferrell 2007 Best practices in diagnostic immunohistochemistry: Hepatocellular carcinoma versus metastatic neoplasms Arch Pathol Lab Med 131 1648 1654 17979482 (Pubitemid 350077461)
20. AS Leong RT Sormunen WM Tsui CT Liew 1998 Hep Par 1 and selected antibodies in the immunohistological distinction of Hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma Histopathology 33 318 324 9822920 10.1046/j.1365-2559.1998.00522.x 1:STN:280:DyaK1M%2FktVamtg%3D%3D (Pubitemid 28508880)
21. JF Mosnier C Kandel D Cazals-Hatem, et al. 2009 N-cadherin serves as diagnostic biomarker in intraHepatic and perihilar cholangiocarcinomas Mod Pathol 22 182 190 18622386 10.1038/modpathol.2008.123 1:CAS:528: DC%2BD1MXhtFOls7k%3D
22. A Maitra LA Murakata J Albores-Saavedra 2001 Immunoreactivity for Hepatocyte paraffin 1 antibody in Hepatoid adenocarcinomas of the gastrointestinal tract Am J Clin Pathol 115 689 694 11345832 10.1309/5C2C-FP3H-GE7Q-2XJ5 1:CAS:528:DC%2BD3MXjvVansrg%3D (Pubitemid 33051535)
23. A Lugli L Tornillo M Mirlacher M Bundi G Sauter LM Terracciano 2004 Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3, 940 tissue samples Am J Clin Pathol 122 721 727 15491968 10.1309/KC09YTF2M4DLUYQ6 1:CAS:528:DC%2BD2cXhtVaksLfK (Pubitemid 39434753)
24. Z Fan M van de Rijn K Montgomery RV Rouse 2003 Hep par 1 antibody stain for the differential diagnosis of Hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections Mod Pathol 16 137 144 12591966 10.1097/01.MP.0000052103.13730.20 (Pubitemid 36245745)
25. MT Mac F Chung F Lin P Hui BL Balzer HL Wang 2009 Expression of Hepatocyte antigen in small intestinal epithelium and adenocarcinoma Am J Clin Pathol 132 80 85 19864237 10.1309/AJCPUD0P5NQBOYPK
26. T Mizoshita T Tsukamoto H Nakanishi, et al. 2003 Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis J Cancer Res Clin Oncol 129 727 734 14557879 10.1007/s00432-003-0499-6 1:CAS:528:DC%2BD3sXptlekuro%3D (Pubitemid 38002304)
27. H Seno M Oshima MA Taniguchi, et al. 2002 CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications Int J Oncol 21 769 774 12239615 1:STN:280:DC%2BD38vnslemug%3D%3D
28. K Matsumoto T Mizoshita T Tsukamoto, et al. 2004 Cdx2 expression in pancreatic tumors: relationship with prognosis of invasive ductal carcinomas Oncol Rep 12 1239 1243 15547744 1:CAS:528:DC%2BD2MXitFOltg%3D%3D
29. DE Hansel A Maitra JW Lin, et al. 2005 Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater J Clin Oncol 23 1811 1818 15774774 10.1200/JCO.2005.03.068 1:CAS:528:DC%2BD2MXjt1Ckurs%3D (Pubitemid 46211359)
30. SM Hong H Cho CA Moskaluk HF Frierson Jr E Yu JY Ro 2005 CDX2 and MUC2 protein expression in extraHepatic bile duct carcinoma Am J Clin Pathol 124 361 370 16191504 10.1309/GTU1Y77MVR4DX5A2 1:CAS:528:DC%2BD2MXhtVCks73O (Pubitemid 41232922)
31. S Kakar T Muir LM Murphy RV Lloyd LJ Burgart 2003 Immunoreactivity of Hep Par 1 in Hepatic and extraHepatic tumors and its correlation with albumin in situ hybridization in Hepatocellular carcinoma Am J Clin Pathol 119 361 366 12645337 10.1309/8L872RPHEJRKF5JJ (Pubitemid 37047858)
32. JA Ramos-Vara MA Miller 2002 Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to Hepatocyte paraffin 1 (Hep Par 1) Histochem J 34 397 401 12814187 10.1023/A:1023683404230 1:CAS:528:DC%2BD3sXjtlantbs%3D (Pubitemid 36683644)
33. M Hishinuma KI Ohashi N Yamauchi, et al. 2006 Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma Histopathology 49 479 486 17064293 10.1111/j.1365-2559.2006. 02522.x 1:STN:280:DC%2BD28njtFahsg%3D%3D (Pubitemid 44631620)